Post by 2BScientific GmbH

Supporting neuro-oncology research with high-quality biosimilars from ichorbio – plus your last chance to save 10% across the entire ichorbio biosimilar range. Primary brain tumours and CNS malignancies remain among the most challenging cancers to study, highlighting the need for reliable, high-quality research tools. ichorbio's portfolio of research-grade biosimilars supports neuro-oncology research across glioblastoma, glioma and neuroblastoma. With biosimilars targeting key molecules including EGFR, VEGF, GD2 and CD276, researchers can investigate tumour signalling, angiogenesis and mechanisms of therapeutic resistance. Last chance to save! Researchers in Germany can receive 10% off all ichorbio biosimilars when ordering through 2BScientific GmbH. Simply quote 2BS-ICHOR10 when placing your order. But don't delay, offer finishes June 30th! Discover the full range and claim your discount: https://lnkd.in/errbRMDa #NeuroOncology #CancerResearch #Biosimilars